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To  determine the minimal structural  requirements for shared idiotypy, we 
tested the lectin of the horseshoe crab, Limulus polyphemus, for its capacity to 
react with monoclonal antibodies directed against idiotypic determinants on the 
phosphorylcholine-binding murine myeloma protein TEPC-15. This model was 
chosen because the Limulus lectin binds phosphorylcholine as well as sialic acid 
(1)  and  shows a  number of similarities to  the acute-phase protein  C-reactive 
protein  (CRP) 1 that  binds  phosphorylcholine (2)  and  expresses  determinants 
cross-reactive with the idiotypes of phosphorylcholine-binding myeloma proteins 
(3). The structure of horseshoe crab lectin is considerably different from that of 
vertebrate immunoglobulins (4-6). Moreover, Limulus, an ancient arachnoid, is 
a  "living fossil"  that has had an evolution completely distinct from that of the 
vertebrates (7).  We assessed the capacity of monoclonal antibodies specific for 
idiotypic determinants of the TEPC-15 molecule (3, 8,  9) to bind to horseshoe 
crab lectin in the presence or absence of phosphorylcholine derivatives or sialic 
acid. We report that the lectin cross-reacts with TEPC-15 and CRP using defined 
monoclonal antibodies and we identify short stretches of amino acid sequence 
implicated in the cross-reaction and in the binding of hapten. 
Materials and Methods 
Invertebrate  Lectins  and  CRP.  Limulin  (lectin  from  Limulus  polyphemus)  was  either 
obtained  from EY  Labs,  San  Mateo,  CA or prepared  (10)  from Limulus  serum  kindly 
supplied by Dr. J. Granberry, Limulus Laboratories, FL. Didemnum candidum lectin I (DC- 
I) was purified as reported earlier (11). Bovine serum albumin (BSA), bovine submaxillary 
mucin  (BSM),  N-acetylneuraminic  acid  (NANA)  type  VI,  phosphorylcholine  chloride 
(Ca  ++ salt) (PC), p-nitrophenylphosphorylcholine (pNPPC), and human aracid glycopro- 
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tein  were  purchased  from Sigma  Chemical  Co.,  St.  Louis,  MO  at  the  highest  purity 
available.  The  myeloma protein  TEPC-15  was purchased  from Litton  Bionetics,  Inc., 
Kensington, MD. Human CRP was prepared as reported elsewhere (I 2). We are grateful 
to Dr. J. E. Volanakis, University of Alabama, Birmingham, AL for the generous gifts of 
human CRP and rabbit anti-CRP antisera (Rb c~-CRP). 
Monoclonal Antibodies (MAb).  Anti-TEPC-15  idiotype (Id)  MAb  4C11  and  F6  were 
produced as described earlier (9) and purified on TEPC-15-Sepharose as reported else- 
where  (13).  The production  and  characterization  of all  other  anti-TEPC-15  Id  MAb 
tested in the present report has been described previously (8).  MAb specific for anti-al_s 
dextran idiotypic determinants were obtained as previously reported (14).  MAb DBI-1, 
GB4-10, B2-44, and AB1-2 to TEPC-15 and all antidextran Id were the generous gift of 
Dr. J. F. Kearney, University of Alabama, Birmingham. 
Enzyme-linked Immunoadsorbent  Assay (ELISA).  The reactivity of mAB for myeloma and 
acute-phase proteins and lectins was assessed by an ELISA carried out in accord with our 
previously published procedures (15). When capabilities of certain molecules (NANA, PC, 
pNPPC, BSM) to inhibit the binding of MAb to test proteins was examined, 50 #1 of the 
inhibitor solutions in Tris-buffered saline (100 mM Tris HC1, 50 mM NaCI, 10 mM CaCl~, 
pH 7.6) were incubated on the coated plates for 45 min at room temperature. 50 td of 
the MAb (5 ttg/ml) serial dilutions were added to the wells and incubated for another 45 
min. Plates were washed and the procedure was followed as described (15). 
Results 
MAb specific for CRP,  TEPC-15  idiotype, and antidextran  idiotypes showed 
diverse cross-reactivities (Table  I) when  tested  in  ELISA with  the  acute-phase 
protein CRP (which binds PC), the myeloma protein TEPC-15 (which binds PC), 
and  the  serum  lectin  (limulin)  from  the  American  horseshoe  crab  Limulus 
polyphemus,  specific for sialoconjugates and also reported to bind PC (1). MAb of 
anti-CRP  specificity cross-reacted with  TEPC-15  but  not  with limulin,  whereas 
antidextran  Id-specific  MAb  were  negative  for all  proteins  tested,  as  was  the 
MAb specific for insulin  that  was tested as negative control.  All anti-TEPC-15 
Id-specific MAb showed strong reactions with TEPC-15 and many of them cross- 
reacted  intensely  with  limulin  and  CRP.  The  antiserum  Rb a-CRP also  cross- 
reacted  with  limulin.  Other  proteins  that  were  tested,  the  acute  phase oq-acid 
glycoprotein and the lectin DC-I, from the tunicate Didemnum candidum, specific 
TABLE  I 
Reactivity of Lectins, Acute-Phase Proteins and Myeloma Proteins with 
MAb and Rabbit Anti-CRP Antibodies 
Antibody code  Specificity 
Reactivity (ELISA)* 
CRP  TEPC-15 Limulin 
AB1-2  Anti-T15 Id (needs light + heavy  +  +  - 
GB4-10  chain)  +  +  3= 
B24-44  Anti-T  15 Id  +  +  +  + 
DB 1  -  1  Anti-T  15 Id  ÷  specific  (made  +  +  + 
against isolated T 15 heavy 
chain) 
F6  Anti-T  15 ld  +  +  + 
4C11  Anti-T15 Id  +  +  + 
Rb a-CRF  Anti-CRP  +  +  + 
* a,-Acid glycoprotein  (human), DC-I,  and BSA were negative  for all MAb and Rb 
a-CRP. All antidextran ld MAb tested were  negative  with CRP, TEPC-15, limulin, 
al-acid glycoprotein,  DC-I,  and BSA. 1272  TEPC-15 1DIOTYPE ON  LIMULIN 
for  galactosyl  residues,  did  not  show  any  cross-reactivity  with  the  MAb  and 
neither did BSA, included as a negative control. 
The strongest cross-reactivities with limulin were observed with the MAb DB 1- 
1  (anti-TEPC-15  variable  region  heavy  chain  (V.)  specific,  made  against  the 
isolated TEPC-15 heavy chain),  F6 (anti-TEPC-15  Id), and 4C 11  (anti-T 15 Id). 
F6 and 4C 11  titrated almost identically with CRP and limulin, as shown in Fig. 
1, where titration curves for TEPC-15, DC-I, and BSA are also shown. 
We confirmed the specificity of the anti-TEPC-15  Id MAb and the nature of 
the binding site recognized on CRP and limulin by testing the binding of F6 and 
4Cll  MAb  in  the  presence  of PC,  pNPPC,  NANA,  and  BSM  alternatively. 
Titration curves (Fig. 2) of MAb F6 and 4C 11 tested with limulin and CRP were 
not modified with respect to the buffer controls by the presence of NANA (100 
mM) or BSM (100 t~g/ml).  However, the intensity of the reaction was strongly 
decreased when  the  titration  was performed  in  the  presence  of pNPPC  (100 
mM). The sodium salt of PC (100 mM) was a less powerful inhibitor than the p- 
nitrophenyl derivative. 
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FIGURE 1.  Binding  by ELISA of MAb directed against idiotypic  determinants of the TEPC- 
15 immunoglobulin to limulin and CRP. MAb tested: 4C11 (A) and F6 (B). Proteins: TEPC- 
15 (0), CRP ([2]), limulin (0), D. candidum lectin (&), and BSA (A). VASTA,  MARCHALONIS,  AND  KOHLER  1273 
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FIGURE 2.  Inhibition assay to determine the effects of NANA and pNPPC on the binding of 
MAb F6 and 4C11  directed against TEPC-15  idiotypic determinants to limulin and CRP. 
MAb F6 is used in A and C, 4C11 in B and D. Limulin is tested in A and B, CRP in C and D. 
No inhibitor (PBS control) U); NANA (O); pNPPC (0). 
Discussion 
Our results show that  the lectin  of an  ancient arachnoid  bears a  serological 
determinant  detectable using MAb directed against an antigen-specific Id of a 
murine myeloma protein. Using rabbit antisera directed against human CRP, we 
showed that  the horseshoe crab lectin  is cross-reactive with  CRP.  Using  MAb 
specific for  the  TEPC-15  Id,  we  found  that  some of these  (DBI-1,  F-6,  and 
4C11)  showed clear reactivity with  both horseshoe crab lectin and  CRP.  The 
horseshoe  crab  lectin  shares  "idiotopes"  with  TEPC-15  but  it  is  clearly  not 
equivalent to TEPC-15  Id because all of the MAb we tested bound strongly to 
the immunoglobulin, whereas many MAb to TEPC-15 or to related V. structures 
did not react with the limulin molecule. The capacity of the MAb to react with 
horseshoe crab lectin was diminished by using pNPPC, indicating that the anti- 
Id and  the  hapten  were competing for the  combining  site.  Free sialic acid or 
sialoproteins, by contrast,  did not block the binding of MAb to limulin.  There- 1274  TEPC-15 IDIOTYPE ON  LIMULIN 
fore, the binding sites for sialic acid and PC are distinct on the lectin molecule 
and are probably spacially distant, accounting for the lack of cross-inhibition. 
Neither CRP (16) nor limulin (6) show significant overall sequence homology 
to vertebrate immunoglobulins. We used the computer program RELATE (17) 
to consider sequence stretches of 6 and 10 amino acids to identify short regions 
of significant sequence identity that might account for the observed serological 
cross-reaction between CRP and limulin and the binding of MAb to the TEPC- 
15  Id of both molecules. The only stretch of significant identity between the 
sequenced portion of limulin and CRP corresponded to 59-71  in limulin and 
52-64 in CRP. 9 of 13 positions were identical within this stretch, as follows: 
Limulin  F S Y A T  AK K D N ELL 
CRP  FSYATKRQDNEI  L 
The application of the same analysis to a  comparison of TEPC-15 and CRP 
identified a stretch of CRP sequence corresponding to residues 83-92 of CRP 
and residues 60-69  of TEPC-15.  This  short stretch showed 50%  identity of 
residues.  A  comparison between TEPC-15  and limulin identified a  stretch of 
sequence that  overlapped the one identified in  the TEPC-15/CRP  sequence. 
The stretch corresponded to residues 64-71  of TEPC-15 and 47-54 of limulin. 
This limited stretch of sequence likewise showed 50% identity. These sequences 
are illustrated as follows: 
TEPC-15  SASVKGRFI  VSR 
Limulin  K G T L G  H S R 
CRP  SASGI  VEFWV 
Although the shared residues are not identical in the comparisons of limulin 
and CRP with TEPC-15, these stretches overlap and the binding of MAb anti- 
Id can be blocked by hapten. The region of TEPC- 15 V. identified corresponds 
to the juncture of the second complementarity-determining region (CDR2) and 
the third framework (FR3) segments. Additional evidence that this CDR2/FR3 
sequence stretch is  critical  is  the fact  that  monoclonal anti-TEPC  is  GB4-10 
which reacts with D region sequence (18) and binds only marginally to CRP and 
limulin and that the proposed region identified here is potentially an exposed 
antigen site, on the basis of computer analysis of hydrophilicity (19). The lengths 
of shared  sequence,  correlated  with  shared  antigenicity and  ligand  binding, 
correspond in size (6-15  residues) to that stated as optimal for the production 
of antipeptide antibodies that react with the intact protein (20). 
Although it might be concluded that the sharing of relatively short stretches 
of sequence between classic immunoglobulins and nonimmunoglobulin molecules 
most probably illustrates a  convergent evolution in  which different molecules 
reactive with a  common ligand are forced to  use similar residues to form the 
combining site,  another interpretation  that  might account for the sharing of 
idiotype (21) as well as the definition of V. allotype (22) is the insertion of short 
DNA  segments  or  minigenes  (23)  into  different  framework sequences.  Our 
results are clearly pertinent to the use of antibodies directed against idiotypic 
immunoglobulin Id determinants as probes for receptors on lymphocytes or on 
antigen-specific factors, because they indicate that only a  very short stretch of VASTA, MARCHALONIS, AND KOHLER  1275 
sequence is required to allow sharing of combining site-related idiotopes among 
totally unrelated molecules. 
Summary 
To estimate the minimal structural requirements for cross-reaction of idiotypic 
determinants, we determined the capacity of monoclonal antibodies specific for 
the idiotype of the phosphorylcholine (PC)-binding myeloma protein TEPC-15 
for cross-reactivities with the PC-binding, acute-phase protein C-reactive protein 
(CRP) and the hemagglutinin from the horseshoe crab Limulus polyphemus  (li- 
inulin), which binds sialic acid and PC. Certain monoclonal antibodies (MAb) to 
the TEPC-15 idiotype showed strong cross-reactions with CRP and limulin when 
tested by enzyme-linked immunoadsorbent assays.  The specificity of the cross- 
reactivities was confirmed by testing the binding of the reactive anti-TEPC-15 
MAb to both CRP and limulin in the presence ofp-nitrophenylphosphorylcholine 
(pNPPC), N-acetylneuraminic acid, and bovine submaxillary mucin. The binding 
of the MAb to both CRP and limulin was strongly decreased by pNPPC, partially 
decreased by free PC,  and not affected by N-acetylneuraminic acid or bovine 
submaxillary mucin.  Neither  CRP  nor  limulin  showed  significant  overall  se- 
quence homology to vertebrate immunoglobulins. However, CRP, limulin, and 
TEPC-15  variable region heavy chain (V.) shared short stretches of homology 
(8-10 amino acids) that mapped to a  stretch comprised of the second comple- 
mentarity determining region and third framework region of the TEPC-15 V,. 
These results might reflect either evolutionary convergence forced upon mole- 
cules of diverse evolutionary histories because of steric requirements of binding 
the same ligand, or a conservation of primitive combining site gene segments in 
evolution. 
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